About this opportunity:
At Freenome, we are seeking a Sr. Director, Finance to build and shape our Finance team. The ideal candidate will be a strategic and hands-on leader with experience building scalable public company finance organizations. This is a high-impact leadership role responsible for the Financial Planning and Analysis (FP&A), business partnering, and finance operations functions. This role offers a unique opportunity to architect our financial engine. You won’t just be reporting numbers, you will be building the systems, teams and insights that guide our executive team. You will be instrumental in enabling Freenome to bring our early detection tests to patients - changing the entire landscape of cancer.
The role reports to the Chief Financial Officer (CFO). This role will be an Onsite role based in our Brisbane, California headquarters.
What you’ll do:
Must haves:
Nice to haves:
Benefits and additional information:
The US target range of our base salary for new hires is $229,900 - $294,788 You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
#LI-ONSITE

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.